Down syndrome and the complexity of genome dosage imbalance.
about
Genetic Approaches to Understanding Psychiatric Disease.Comparative transcriptomics in human and mouse.Predispositions to Leukemia in Down Syndrome and Other Hereditary Disorders.Diagnosis and classification of hematologic malignancies on the basis of genetics.Chromosome 21-Encoded microRNAs (mRNAs): Impact on Down's Syndrome and Trisomy-21 Linked Disease.Dosage-sensitive genes in evolution and disease.A microRNA cluster (let-7c, miRNA-99a, miRNA-125b, miRNA-155 and miRNA-802) encoded at chr21q21.1-chr21q21.3 and the phenotypic diversity of Down's syndrome (DS; trisomy 21)Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits.The spontaneous differentiation and chromosome loss in iPSCs of human trisomy 18 syndrome.Dysregulation of neurotrophin signaling in the pathogenesis of Alzheimer disease and of Alzheimer disease in Down syndrome.Rodent models in Down syndrome research: impact and future opportunities.Can EGCG Alleviate Symptoms of Down Syndrome by Altering Proteolytic Activity?A third copy of the Down syndrome cell adhesion molecule (Dscam) causes synaptic and locomotor dysfunction in Drosophila.Systematic Functional Characterization of Human 21st Chromosome Orthologs in Caenorhabditis elegans.Identifying Patients with Atrioventricular Septal Defect in Down Syndrome Populations by Using Self-Normalizing Neural Networks and Feature Selection.Targeting Amyloid-β Precursor Protein, APP, Splicing with Antisense Oligonucleotides Reduces Toxic Amyloid-β Production.Analysis of motor dysfunction in Down Syndrome reveals motor neuron degeneration.Integrated Quantitative Transcriptome Maps of Human Trisomy 21 Tissues and Cells.Excess Synaptojanin 1 Contributes to Place Cell Dysfunction and Memory Deficits in the Aging Hippocampus in Three Types of Alzheimer's Disease.DYRK1A Protein, A Promising Therapeutic Target to Improve Cognitive Deficits in Down Syndrome
P2860
Q38728415-8C96D962-9FBD-4B43-A96A-6CB1A4623BDFQ39289394-9B55BE8E-F73C-4937-B36D-305ACFC886A3Q39350289-32FF0FCB-F4ED-4326-9A6D-931A2C813C61Q39363409-F80DC9E5-BF47-448B-A547-D5558F13A851Q39422078-889BD51E-4048-4814-B74C-C8C735D6B492Q41587750-6E6AF094-08EE-40AA-9BAA-450163C60530Q41689316-9E2666C1-A8B5-4ADB-8087-C4BD1420B4B9Q41696401-97F9A2DF-725C-43FB-A9F8-FB11A7D4B9C2Q45902476-AEC2BE4F-BE42-40B0-8097-6ECA2D3A40C8Q46073648-21978CF3-9921-49B5-ACCD-43ED30BC5A0FQ46193918-73BC3C79-90B8-40C9-ABBE-0A9979BE2467Q47558056-941BD605-D46F-4BA8-BEFE-DC2749A7B114Q47690390-30C9A070-8EE3-41BA-894F-1205DB074A4DQ49788245-4DA589D0-07DF-4D17-9D77-20B6C534EC81Q52323602-13DEF3BC-2B22-4F3B-8DCD-0B9AD43B5CB3Q52720869-E4F88BDB-3B71-4E1F-A53E-10850D42D9E5Q55163408-9F6EAF6D-FBC3-4B38-BA97-188AE6218205Q55280442-7A893F7C-D50A-4647-8B01-D97374A884BDQ55645827-788A00A6-FA9A-40C7-A9C5-3FBCAE931DA0Q58551676-AC69B083-7CB7-418C-A3C7-267A344086C0
P2860
Down syndrome and the complexity of genome dosage imbalance.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Down syndrome and the complexity of genome dosage imbalance.
@en
Down syndrome and the complexity of genome dosage imbalance.
@nl
type
label
Down syndrome and the complexity of genome dosage imbalance.
@en
Down syndrome and the complexity of genome dosage imbalance.
@nl
prefLabel
Down syndrome and the complexity of genome dosage imbalance.
@en
Down syndrome and the complexity of genome dosage imbalance.
@nl
P2860
P356
P1476
Down syndrome and the complexity of genome dosage imbalance.
@en
P2093
Stylianos E Antonarakis
P2860
P2888
P304
P356
10.1038/NRG.2016.154
P577
2016-12-28T00:00:00Z